| Literature DB >> 23748153 |
Donatella Granchi1, Alessandro Scarso, Giulio Bianchini, Andrea Chiminazzo, Alberto Minto, Paolo Sgarbossa, Rino A Michelin, Gemma Di Pompo, Sofia Avnet, Giorgio Strukul.
Abstract
Bisphosphonates (BPs) are key drugs for the treatment of bone resorption diseases like osteoporosis, Paget's disease and some forms of tumors. Recent findings underlined the importance of lipophilic N-containing BPs to ensure high biological activity. Herein we present some unprecedented results concerning the low toxicity and good anti-osteoclast activity of low molecular weight hydrophilic S-containing BPs. A series of S and N-containing BPs bearing aromatic and aliphatic substitution were prepared through Michael addition reaction between vinylidenebisphosphonate tetraethyl ester and the proper nucleophile under basic catalysis. S-containing BPs showed a generally low toxicity, determined with the neutral-red assay using the L929 cell line, and, in particular for an aliphatic one, a good biological activity assessed on primary cultures of human osteoclasts.Entities:
Keywords: Apoptosis; Bisphosphonates; Cytotoxicity; Osteoclast; S-containing drugs
Mesh:
Substances:
Year: 2013 PMID: 23748153 DOI: 10.1016/j.ejmech.2013.04.032
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514